NCT07250724
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
At risk: Primary completion moved 3 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 12 words Show 4 more changesShow less
- Enrollment closed, study ongoing
- Primary completion pushed from Oct 15, 2026 to Jan 15, 2027
- Study completion pushed from Oct 15, 2026 to Jan 31, 2027
- Site details revised at 4 of 4 sites
- Notable Eligibility criteria expanded, about 32 words
- Trial sites expanded: 1 → 4 locations
- Minor Start date changed from estimate of Feb 1, 2026 to Mar 1, 2026v4
- Notable Start date: Dec 1, 2025 to Feb 1, 2026
- Site contact updated
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
The proportion of subjects experiencing CDI recurrence in the time period between baseline and end of study follow-up.
Timeframe: Within the 8 week time period between baseline and end of follow-up
Arms and interventions
Other: Participants that are undergoing standard of care antibiotic treatment for their second C. Diff infection will be followed for 8 weeks after completing antibiotic treatment.
Sites
4 sites in 1 country